Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases.
Copyright Nasdaq. Minimum 15 minutes delayed.
Events & Presentations
Feb 27, 2018 at 8:00 AM EST
Ophthotech Corporation Fourth Quarter and Year End 2017 Results Conference Call
Jan 11, 2018 at 5:00 PM EST
36th Annual J.P. Morgan Healthcare Conference